Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease

The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Colorectal Cancer Cardiovascular Diseases Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Duodenal Diseases Gastric Cancer Gastric Ulcer Gastroenteritis Gastrointestinal Diseases Gastrointestinal Neoplasms Hemorrhoids Hernia Inflammatory Bowel Diseases Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Peptic Ulcer Rectal Diseases Stomach Diseases Stomach Neoplasms Stomach Ulcer Vascular Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University

Wuhan, Hubei, 430060, China

Location status: Recruiting

Location contact

Tao Fu, MD

CONTACT

[email protected]

86-13720120190

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery.
Must be willing and able to provide informed consent.

Exclusion criteria

Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.

Treatment and study plan

No intervention will be given to patients.

Other

Samples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.

Primary outcomes

Confirmation of diagnosis by pathologist

Time frame: Up to 3 years

Once tissue is collected, those samples that have a confirmed diagnosis of disease by the pathologist will be used.

Study contacts

Contact information is provided by the study sponsor or research team.

Tao Fu, MD

CONTACT

[email protected]

+8613720120190

Sponsors and collaborators

Lead sponsor

Renmin Hospital of Wuhan University

Other

Registry information

Official study title

Samples Procurement for Patients With Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Undergoing Surgery

Important dates

Study start: 2020
Primary completion: 2023
Study completion: 2026
First posted: Jun 4, 2019
Registry last updated: Apr 29, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed